Microorganisms and autoimmunity: Making the barren field fertile?

Nature Reviews Microbiology

Volumn 1, Issue 2, 2003, Pages 151-157

  Herrath, Matthias G ^a   Fujinami, Robert S ^b   Whitton, J Lindsay ^c  

^a LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^c SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; AUTOIMMUNE DISEASE; AUTOIMMUNITY; BYSTANDER EFFECT; DISEASE MODEL; HUMAN; IMMUNOLOGY; MOUSE; NONOBESE DIABETIC MOUSE; REVIEW; T LYMPHOCYTE; VIRUS INFECTION;

ANIMALS; AUTOIMMUNE DISEASES; AUTOIMMUNITY; BYSTANDER EFFECT; DISEASE MODELS, ANIMAL; HUMANS; MICE; MICE, INBRED NOD; T-LYMPHOCYTES; VIRUS DISEASES;

EID: 1842613450     PISSN: 17401526     EISSN: 17401534     Source Type: Journal    
DOI: 10.1038/nrmicro754     Document Type: Article

References (84)

1. Srinivasappa, J. et al. Molecular mimicry: frequency of reactivity of monoclonal antiviral antibodies with normal tissues. J. Virol. 57, 397-401 (1986).
2. + T cells directed to self-antigens. Eur. J. Immunol. 33, 1409-1417 (2003).
3. Jacobson, D. L., Gange, S. J., Rose, N. R. & Graham, N. M. Epidemiology and estimated population burden of selected autoimmune diseases in the United States. Clin. Immunol. Immunopathol. 84, 223-243 (1997).
4. Nishioka, K., Nakajima, T, Hasunuma, T. & Sato, K. Rheumatic manifestation of human leukemia virus infection. Rheum. Dis. Clin. North Am. 19, 489-503 (1993).
5. Zhao, Z. S. et al. Molecular mimicry by herpes simplex virus-type 1: autoimmune disease after viral infection. Science 279, 1344-1347 (1998).
6. Deshpande, S. P et al. Herpes simplex virus-induced keratitis: evaluation of the role of molecular mimicry in lesion pathogenesis. J. Virol. 75, 3077-3088 (2001).
7. Eddy, S. et al. Myasthenia gravis: another autoimmune disease associated with hepatitis C virus infection. Dig. Dis. Sci. 44, 186-189 (1999).
8. Romero, P M. et al. Rheumatologic and autoimmune manifestations in patients with chronic hepatitis C virus infection. Rev. Esp. Enferm. Dig. 89, 591-598 (1997).
9. McMurray, R. W. & Elbourne, K. Hepatitis C virus infection and autoimmunity. Semln. Arthritis Rheum. 26, 689-701 (1997).
10. James, J. A. & Harley, J. B. B-cell epitope spreading in autoimmunity. Immunol. Rev. 164, 185-200 (1998).
11. Atkinson, M. A. et al. Cellular immunity to a determinant common to glutamate decarboxylase and coxsackie virus in insulin-dependent diabetes. J. Clin. Invest. 94, 2125-2129 (1994).
12. Yoon, J. W., Ihm, S. H. & Kim, K. W. Viruses as a triggering factor of type 1 diabetes and genetic markers related to the susceptibility to the virus-associated diabetes. Diabetes Res. Clin. Pract. 7, S47-S58 (1989).
13. Monteyne, P., Bureau, J. F. & Brahic, M. Viruses and multiple sclerosis. Curr. Opin. Neurobiol. 11, 287-291 (1998).
14. Panitch, H. S. Influence of infection on exacerbations of multiple sclerosis. Ann. Neurol. 36, S25-S28 (1994).
15. Cunningham, M. W. Autoimmunity and molecular mimicry in the pathogenesis of post-streptococcal heart disease. Front. Biosci. 8, S533-S543 (2003).
16. Kirvan, C. A., Swedo, S. E., Heuser, J. S. & Cunningham, M. W. Mimicry and autoantibody-mediated neuronal cell signaling in Sydenham chorea. Nature Med. 9, 914-920 (2003).
17. Lopez-Larrea, C., Gonzalez, S. & Martinez-Borra, J. The role of HLA-B27 polymorphism and molecular mimicry in spondyloarthropathy. Mol. Med. Today 4, 540-549 (1998).
18. Taurog, J. D. & Hammer, R. E. Experimental spondyloarthropathy in HLA-B27 transgenic rats. Clin. Rheumatol. 15, 22-27 (1996).
19. Benoist, C. & Mathis, D. Autoimmunity provoked by infection: how good is the case for T cell epitope mimicry? Nature Immunol. 2, 797-801 (2001).
20. Leon, J. S. & Engman, D. M. The significance of autoimmunity in the pathogenesis of Chagas heart disease. Front. Biosci. 8, E315-E322 (2003).
21. Kierszenbaum, F. Views on the autoimmunity hypothesis for Chagas disease pathogenesis. FEMS Immunol. Med. Microbiol. 37, 1-11 (2003).
22. Fujinami, R. S. & Oldstone, M. B. A. Amino acid homology between the encephalitogenic site of myelin basic protein and virus: mechanism for autoimmunity. Science 230, 1043-1045 (1985).
23. Barnett, L. A., Whitton, J. L., Wada, Y. & Fujinami, R. S. Enhancement of autoimmune disease using recombinant vaccinia virus encoding myelin proteolipid protein. J. Neuroimmunol. 44, 15-25 (1993).
24. Tsunoda, I. et al. Enhancement of experimental allergic encephalomyelitis (EAE) by DNA immunization with myelin proteolipid protein (PLP) plasmid DNA. J. Neuropathol. Exp. Neurol. 57, 758-767 (1998).
25. Ohashi, P. S. et al. Ablation of tolerance and induction of diabetes by virus infection in viral antigen transgenic mice. Cell 65, 305-318 (1991).
26. Oldstone, M. B. A. et al. Virus infection triggers insulin- dependent diabetes mellitus in a transgenic model: role of anti-self (virus) immune response. Cell 65, 319-331 (1991).
27. von Herrath, M. G., Dockter, J. & Oldstone, M. B. A. How virus induces a rapid or slow onset insulin- dependent diabetes mellitus in a transgenic model. Immunity 1, 231-242 (1994).
28. von Herrath, M. G. et al. Coexpression of B7-1 and viral ('self') transgenes in pancreatic β cells can break peripheral ignorance and lead to spontaneous autoimmune diabetes. Immunity 3, 727-738 (1995).
29. Kagi, D. et al. Development of insulitis without diabetes in transgenic mice lacking perforin-dependent cytotoxicity. J. Exp. Med. 183, 2143-2152 (1996).
30. von Herrath, M. G. & Oldstone, M. B. A. Interferon-yis essential for destruction of p cells and development of insulin-dependent diabetes mellitus. J. Exp. Med. 185, 531-539 (1997).
31. Wucherpfennig, K. W. Structural basis of molecular mimicry. J. Autoimmun. 16, 293-302 (2001).
32. Whitton, J. L. et al. Molecular analyses of a five-amino- acid cytotoxic T-lymphocyte (CTL) epitope: an immunodominant region which induces non-reciprocal CTL cross-reactivity. J. Virol. 63, 4303-4310 (1989).
33. Sevilla, N. et al. Virus-induced diabetes in a transgenic model: role of cross-reacting viruses and quantitation of effector T cells needed to cause disease. J. Virol. 74, 3284-3292 (2000).
34. Quinn, A. et al. Induction of autoimmune valvular heart disease by recombinant streptococcal M protein. Infect. Immun. 69, 4072-4078 (2001).
35. Honeyman, M. C. et al. Association between rotavirus infection and pancreatic islet autoimmunity in children at risk of developing type 1 diabetes. Diabetes 49, 1319-1324 (2000).
36. Theil, D. J. et al. Viruses can silently prime for and trigger central nervous system autoimmune disease. J. Neurovirol. 7, 1-8 (2001).
37. Olson, J. K. et al. A virus-induced molecular mimicry model of multiple sclerosis. J. Clin. Invest. 108, 311-318 (2001).
38. Shevach, E. M., Chang, J. T. & Segal, B. M. The critical role of IL-12 and the IL-12R β 2 subunit in the generation of pathogenic autoreactive Th1 cells. Springer Semin. Immunopathol. 21, 249-262 (1999).
39. Tough, D. F. & Sprent, J. Viruses and T cell turnover: evidence for bystander proliferation. Immunol. Rev. 150, 129-142 (1996).
40. Tough, D. F., Borrow, P. & Sprent, J. Induction of bystander T cell proliferation by viruses and type I interferon in vivo. Science 272, 1947-1950 (1996).
41. Murali-Krishna, K. et al. Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection. Immunity 8, 177-187 (1998).
42. + T cells during an acute virus infection. Immunity 8, 167-175 (1998).
43. + T cell responses from primary to persistent phases of Epstein-Barr virus infection. J. Exp. Med. 195, 893-905 (2002).
44. Nguyen, K. B. & Biron, C. A. Synergism for cytokine- mediated disease during concurrent endotoxin and viral challenges: roles for NK and T cell IFN-y production. J. Immunol. 162, 5238-5246 (1999).
45. Gangappa, S. et al. Virus-induced immunoinflammatory lesions in the absence of viral antigen recognition. J. Immunol. 161, 4289-4300 (1998).
46. Haring, J. S., Pewe, L. L. & Perlman, S. Bystander CD8 T cell-mediated demyelination after viral infection of the central nervous system. J. Immunol. 169, 1550-1555 (2002).
47. Horwitz, M. S. et al. Diabetes induced by Coxsackie virus: initiation by bystander damage and not molecular mimicry. Nature Med. 4, 781-785 (1998).
48. Kim, S. K., Brehm, M. A., Welsh, R. M. & Selin, L. K. Dynamics of memory T cell proliferation under conditions of heterologous immunity and bystander stimulation. J. Immunol. 169, 90-98 (2002).
49. Ostler, T., Pircher, H. & Ehl, S. 'Bystander' recruitment of systemic memory T cells delays the immune response to respiratory virus infection. Eur. J. Immunol. 33, 1839-1848 (2003).
50. Murali-Krishna, K. et al. In vivo dynamics of anti-viral CD8 T cell responses to different epitopes. An evaluation of bystander activation in primary and secondary responses to viral infection. Adv. Exp. Med. Biol. 452, 123-142 (1998).
51. Welsh, R. M. & Selin, L. K. No one is naive: the significance of heterologous T-cell immunity. Nature Rev. Immunol. 2, 417-426 (2002).
52. + T cells in heterologous antiviral immunity and immunopathology in the lung. Nature Immunol. 2, 1067-1076 (2001).
53. Lin, M. Y., Selin, L. K. & Welsh, R. M. Evolution of the CD8 T-cell repertoire during infections. Microbes. Infect. 2, 1025-1039 (2000).
54. Welsh, R. M., McNally, J. M., Brehm, M. A. & Selin, L. K. Consequences of cross-reactive and bystander CTL responses during viral infections. Virology 270, 4-8 (2000).
55. Selin, L. K. et al. Attrition of T cell memory: selective loss of LCMV epitope-specific memory CD8 T cells following infections with heterologous viruses. Immunity 11, 733-742 (1999).
56. Ahmed, Z. et al. Myelin/axonal pathology in interleukin-12 induced serial relapses of experimental allergic encephalomyelitis in the Lewis rat. Am. J. Pathol. 158, 2127-2138 (2001).
57. von Herrath, M. G., Allison, J., Miller, J. F. & Oldstone, M. B. Focal expression of interleukin-2 does not break unresponsiveness to 'self' (viral) antigen expressed in p cells but enhances development of autoimmune disease (diabetes) after initiation of an anti-self immune response. J. Clin. Invest. 95, 477-485 (1995).
58. Holz, A., Brett, K. & Oldstone, M. B. Constitutive p cell expression of IL-12 does not perturb self-tolerance but intensifies established autoimmune diabetes. J. Clin. Invest. 108, 1749-1758 (2001).
59. Lee, M. S. et al. Sensitization to self (virus) antigen by in situ expression of murine interferon-gamma. J. Clin. Invest. 95, 486-492 (1995).
60. Seewaldt, S. et al. Virus-induced autoimmune diabetes: most beta-cells die through inflammatory cytokines and not perforin from autoreactive (anti-viral) cytotoxic T-lymphocytes. Diabetes 49, 1801-1809 (2000).
61. Gale, C. R. & Martyn, C. N. Migrant studies in multiple sclerosis. Prog. Neurobiol. 47, 425-448 (1995).
62. Schwarze, J. & Gelfand, E. W. The role of viruses in development or exacerbation of atopic asthma. Clin. Chest Med. 21, 279-287 (2000).
63. Schwarze, J. & Gelfand, E. W. Respiratory viral infections as promoters of allergic sensitization and asthma in animal models. Eur. Respir J. 19, 341-349 (2002).
64. Cohen, I. R. Antigenic mimicry, clonal selection and autoimmunity. J. Autoimmun. 16, 337-340 (2001).
65. Christen, U. et al. A dual role for TNFa in type 1 diabetes: islet-specific expression abrogates the ongoing autoimmune process when induced late but not early during pathogenesis. J. Immunol. 166, 7023-7032 (2001).
66. Jacob, C. O. et al. Prevention of diabetes in nonobese diabetic mice by tumor necrosis factor (TNF): similarities between TNFa and interleukin 1. Proc. Natl Acad. Sci. USA 87, 968-972 (1990).
67. Tracy, S. et al. Toward testing the hypothesis that group B coxsackieviruses (CVB) trigger insulin-dependent diabetes: inoculating nonobese diabetic mice with CVB markedly lowers diabetes incidence. J. Virol. 76, 12097-12111 (2002).
68. Barnett, L. A., Whitton, J. L., Wang, L. Y. & Fujinami, R. S. Virus encoding an encephalitogenic peptide protects mice from experimental allergic encephalomyelitis. J. Neuroimmunol. 64, 163-173 (1996).
69. Coon, B., An, L. L., Whitton, J. L. & von Herrath, M. G. DNA immunization to prevent autoimmune diabetes. J. Clin. Invest. 104, 189-194 (1999).
70. von Herrath, M. G. & Whitton, J. L. DNA vaccination to treat autoimmune diabetes. Ann. Med. 32, 285-292 (2000).
71. Robinson, W. H., Steinman, L. & Utz, P J. Protein and peptide array analysis of autoimmune disease. Biotechniques 6, S66-S69 (2002).
72. Lee, M. S. et al. Sensitization to self (virus) antigen by in situ expression of murine interferon-gamma. J. Clin. Invest. 95, 486-492 (1995).
73. Seewaldt, S. et al. Virus-induced autoimmune diabetes: most beta-cells die through inflammatory cytokines and not perforin from autoreactive (anti-viral) cytotoxic T-lymphocytes. Diabetes 49, 1801-1809 (2000).
74. Gale, C. R. & Martyn, C. N. Migrant studies in multiple sclerosis. Prog. Neurobiol. 47, 425-448 (1995).
75. Schwarze, J. & Gelfand, E. W. The role of viruses in development or exacerbation of atopic asthma. Clin. Chest Med. 21, 279-287 (2000).
76. Schwarze, J. & Gelfand, E. W. Respiratory viral infections as promoters of allergic sensitization and asthma in animal models. Eur. Respir J. 19, 341-349 (2002).
77. Cohen, I. R. Antigenic mimicry, clonal selection and autoimmunity. J. Autoimmun. 16, 337-340 (2001).
78. Christen, U. et al. A dual role for TNFa in type 1 diabetes: islet-specific expression abrogates the ongoing autoimmune process when induced late but not early during pathogenesis. J. Immunol. 166, 7023-7032 (2001).
79. Jacob, C. O. et al. Prevention of diabetes in nonobese diabetic mice by tumor necrosis factor (TNF): similarities between TNFa and interleukin 1. Proc. Natl Acad. Sci. USA 87, 968-972 (1990).
80. Tracy, S. et al. Toward testing the hypothesis that group B coxsackieviruses (CVB) trigger insulin-dependent diabetes: inoculating nonobese diabetic mice with CVB markedly lowers diabetes incidence. J. Virol. 76, 12097-12111 (2002).
81. Barnett, L. A., Whitton, J. L., Wang, L. Y. & Fujinami, R. S. Virus encoding an encephalitogenic peptide protects mice from experimental allergic encephalomyelitis. J. Neuroimmunol. 64, 163-173 (1996).
82. Coon, B., An, L. L., Whitton, J. L. & von Herrath, M. G. DNA immunization to prevent autoimmune diabetes. J. Clin. Invest. 104, 189-194 (1999).
83. von Herrath, M. G. & Whitton, J. L. DNA vaccination to treat autoimmune diabetes. Ann. Med. 32, 285-292 (2000).
84. Robinson, W. H., Steinman, L. & Utz, P J. Protein and peptide array analysis of autoimmune disease. Biotechniques 6, S66-S69 (2002).